These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27799281)

  • 61. Glioma biology and molecular markers.
    Cohen AL; Colman H
    Cancer Treat Res; 2015; 163():15-30. PubMed ID: 25468223
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of gliomas: from morphology to molecules.
    Ferris SP; Hofmann JW; Solomon DA; Perry A
    Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.
    Miller JJ; Shih HA; Andronesi OC; Cahill DP
    Cancer; 2017 Dec; 123(23):4535-4546. PubMed ID: 28980701
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Advance of molecular subtyping and precise treatment for gliomas].
    Hua W; Mao Y
    Zhonghua Wai Ke Za Zhi; 2017 Jan; 55(1):63-66. PubMed ID: 28056258
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular classification of adult gliomas: recent advances and future perspectives.
    Barritault M; Meyronet D; Ducray F
    Curr Opin Oncol; 2018 Nov; 30(6):375-382. PubMed ID: 30148717
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics.
    Synhaeve NE; van den Bent MJ; French PJ; Dinjens WNM; Atmodimedjo PN; Kros JM; Verdijk R; Dirven CMF; Dubbink HJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):126. PubMed ID: 30470264
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report.
    van der Meulen M; Ramos RC; Mason WP; Von Deimling A; Maas SLN
    Neurology; 2022 Nov; 99(20):903-908. PubMed ID: 36240081
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular diagnostics of gliomas.
    Nikiforova MN; Hamilton RL
    Arch Pathol Lab Med; 2011 May; 135(5):558-68. PubMed ID: 21526954
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Classification and Diagnosis of Adult-Type Diffuse Gliomas].
    Ohno M; Sugino H
    No Shinkei Geka; 2023 Sep; 51(5):760-770. PubMed ID: 37743327
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genetics and epigenetics of gliomas.
    Suvà ML
    Swiss Med Wkly; 2014; 144():w14018. PubMed ID: 25356909
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Algorithm for the integrated diagnosis of gliomas 2021. Our experience].
    Merenzon MA; Gómez Escalante JI; Prost D; Seoane E; Mazzón A; Rojas Bilbao É
    Medicina (B Aires); 2022; 82(3):370-375. PubMed ID: 35639057
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diffuse Gliomas for Nonneuropathologists: The New Integrated Molecular Diagnostics.
    Lee SC
    Arch Pathol Lab Med; 2018 Jul; 142(7):804-814. PubMed ID: 29775073
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
    Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X
    Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approaches.
    Billard P; Guerriau C; Carpentier C; Juillard F; Grandin N; Lomonte P; Kantapareddy P; Dufay N; Barritault M; Rimokh R; Verrelle P; Maucort-Boulch D; Figarella-Branger D; Ducray F; Dehais C; Charbonneau M; Meyronet D; Poncet DA;
    Ann Oncol; 2021 Dec; 32(12):1608-1617. PubMed ID: 34690007
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma.
    Kim SI; Lee K; Bae J; Lee S; Yun H; Park CK; Choi SH; Maquiling CA; Park SH; Won JK
    Brain Tumor Pathol; 2021 Oct; 38(4):271-282. PubMed ID: 34338912
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification.
    Olar A; Sulman EP
    Semin Radiat Oncol; 2015 Jul; 25(3):155-63. PubMed ID: 26050585
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic significance of genetic biomarkers in isocitrate dehydrogenase-wild-type lower-grade glioma: the need to further stratify this tumor entity - a meta-analysis.
    Vuong HG; Tran TTK; Ngo HTT; Pham TQ; Nakazawa T; Fung KM; Hassell L; Katoh R; Kondo T
    Eur J Neurol; 2019 Mar; 26(3):379-387. PubMed ID: 30298540
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Brain Tumor].
    Komori T
    Brain Nerve; 2020 Apr; 72(4):399-405. PubMed ID: 32284464
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular pathology of tumors of the central nervous system.
    Kristensen BW; Priesterbach-Ackley LP; Petersen JK; Wesseling P
    Ann Oncol; 2019 Aug; 30(8):1265-1278. PubMed ID: 31124566
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunohistochemical expression of HIF-1α, IDH1 and TP53: Prognostic profile of Moroccan patients with diffuse glioma.
    Sfifou F; Ouzir M; Hakkou EM; Obtel M; Errihani H; Bouzidi AA; Abouqal R; El Ouahabi A; Cherradi N
    J Chem Neuroanat; 2022 Jan; 119():102056. PubMed ID: 34871733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.